Health Condition 1: G43- Migraine
Conditions
Interventions
Intervention1: Individualized homeopathic medicines: Each dose will constitute of 1/10th of the solution of a single globule no. 10 (poppy-seed size
moistened with the individualized remedy prepared with 83.1% v/v ethanol) in 100 ml of distilled water and 5 drops of ethanol, taken after 10 equal downward strokes to the bottle in half cup of water,
moistened with ethanol only) in 100 ml of distilled water and 5 drops of ethanol, taken after 10 equal downward strokes to the bottle in half cup of water, to stir well and to take single spoonful (5
Sponsors
Central Council for Research in Homeopathy Government of India
Eligibility
Inclusion criteria
Inclusion criteria: 1.Migraine sufferers with or without aura, diagnosed as per ICHD-3 beta classification of headache, 2013 2.History of suffering from migraine for at least one year 3.Age range 12 to 65 years 4.Both sexes 5.Given written consent for the study 6.Willingness to comply with probable dietary regimes advised by the treating physician, especially refraining from strong coffee, peppermint, camphor and other substances with strong odors. Note: Patients on life-saving conventional drug therapies, e.g. anti-diabetics, anti-hypertensives, thyroid drugs etc. for co-morbidities under control, as well as ââ?¬Ë?rescue analgesicsââ?¬• as and when required will be continued.
Exclusion criteria
Exclusion criteria: 1.Patients with transformed migraine or who were previously diagnosed with chronic diseases known to have influence on migraine specific quality of life scores, such as depression, diabetes, osteoarthritis, congestive heart failure, hypertension, angina, myocardial infarction, asthma or chronic low back pain [24] 2.Other headaches more troublesome than migraine, or other causes of chronic or recurrent pain 3.Overt depression 4.Spinal trauma within the last 4 years 5.Use of specific migraine prophylactics within 2 months prior to entry 6.Cases with other systemic unevaluated, uncontrolled and/or complicated diseases or infections affecting quality of life 7.Psychiatric illness 8.Change in use of oral contraceptives in the previous 6 months, or during the trial 9.Patients with any vital organ failure 10.History of homeopathic treatment for any chronic disease within last 6 months 11.Self-reported immune-compromised states 12.Alcohol and /or drug addiction or dependence 13.Lactation and pregnancy 14.Not giving written consent form
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Lowering of intensity (100 mm VAS), duration (hours/day) and frequency (attacks/month) of migraine episodeTimepoint: 6 months | — |
Secondary
| Measure | Time frame |
|---|---|
| Improvement in migraine screen questionnaire (MSQ), headache specific quality of life questionnaire (HSQoLQ) headache management questionnaire (HMQ), and headache disability questionnaire (HDQ); patients assessed globally as improved by the physician; change in consumption of ââ?¬Ë?rescue analgesicsââ?¬â?¢; safety of treatment; occurrence of adverse or serious adverse event(s) (AE/SAE); withdrawal due to AE(s)/SAE(s) or lack of efficiency; and number of deathsTimepoint: 6 months | — |
Countries
India
Contacts
Public ContactSubhranil Saha
Central Council for Research in Homeopathy Government of India
Outcome results
None listed